Transcode Therapeutics Correlations

RNAZ Stock

USD 9.02 0.48 5.62%

The current 90-days correlation between Transcode Therapeutics and Lyra Therapeutics is 0.04 (i.e., Significant diversification). The correlation of Transcode Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Transcode Therapeutics Correlation With Market

Average diversification

The correlation between Transcode Therapeutics and DJI is 0.11 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Transcode Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with Transcode Stock

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Transcode Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For more information on how to buy Transcode Stock please use our How to Invest in Transcode Therapeutics guide.

Moving together with Transcode Stock

0.85	LIPO	Lipella Pharmaceuticals	Pair Corr
0.8	HPQ	HP Inc	Pair Corr
0.78	HD	Home Depot	Pair Corr

Moving against Transcode Stock

0.89	DD	Dupont De Nemours	Pair Corr
0.85	TRV	The Travelers Companies Earnings Call This Week	Pair Corr
0.83	ATI	Allegheny Technologies	Pair Corr
0.81	AMGN	Amgen Inc	Pair Corr
0.8	CSCO	Cisco Systems	Pair Corr
0.77	BOF	BranchOut Food Common	Pair Corr
0.76	WSFS	WSFS Financial	Pair Corr
0.76	F	Ford Motor	Pair Corr
0.76	BAC	Bank of America	Pair Corr
0.75	XOM	Exxon Mobil Corp Aggressive Push	Pair Corr
0.74	AXP	American Express	Pair Corr
0.71	ACR-PC	ACRES Commercial Realty	Pair Corr
0.7	ASXSF	Elysee Development Corp	Pair Corr
0.68	JNJ	Johnson Johnson Earnings Call This Week	Pair Corr
0.67	JPM	JPMorgan Chase	Pair Corr
0.63	PFE	Pfizer Inc	Pair Corr
0.62	ACN	Accenture plc	Pair Corr
0.6	IBM	International Business	Pair Corr
0.55	GILD	Gilead Sciences	Pair Corr
0.55	KO	Coca Cola Aggressive Push	Pair Corr
0.43	MMM	3M Company Earnings Call This Week	Pair Corr

Related Correlations Analysis

	INAB	LYRA	APVO	GLTO	PHIO	HCWB	KPRX	APRE	BOLT	ACXP
INAB		0.2	-0.36	-0.29	0.3	0.04	0.29	0.11	0.64	0.08	INAB
LYRA	0.2		0.72	-0.69	0.92	0.91	0.86	0.83	0.32	0.91	LYRA
APVO	-0.36	0.72		-0.54	0.7	0.85	0.53	0.81	-0.22	0.8	APVO
GLTO	-0.29	-0.69	-0.54		-0.8	-0.78	-0.62	-0.81	-0.13	-0.68	GLTO
PHIO	0.3	0.92	0.7	-0.8		0.94	0.88	0.91	0.34	0.92	PHIO
HCWB	0.04	0.91	0.85	-0.78	0.94		0.82	0.94	0.12	0.95	HCWB
KPRX	0.29	0.86	0.53	-0.62	0.88	0.82		0.7	0.47	0.82	KPRX
APRE	0.11	0.83	0.81	-0.81	0.91	0.94	0.7		0.03	0.9	APRE
BOLT	0.64	0.32	-0.22	-0.13	0.34	0.12	0.47	0.03		0.19	BOLT
ACXP	0.08	0.91	0.8	-0.68	0.92	0.95	0.82	0.9	0.19		ACXP
	INAB	LYRA	APVO	GLTO	PHIO	HCWB	KPRX	APRE	BOLT	ACXP

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

ACXP	+ 0.95	HCWB
HCWB	+ 0.94	PHIO
APRE	+ 0.94	HCWB
PHIO	+ 0.92	LYRA
ACXP	+ 0.92	PHIO
HCWB	+ 0.91	LYRA

High negative correlations

APRE	- 0.81	GLTO
PHIO	- 0.8	GLTO
HCWB	- 0.78	GLTO
GLTO	- 0.69	LYRA
ACXP	- 0.68	GLTO
KPRX	- 0.62	GLTO

Risk-Adjusted Indicators

There is a big difference between Transcode Stock performing well and Transcode Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Transcode Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
INAB	4.56	(0.01)	0.00	0.10	4.71	(6.66)	14.29	(9.87)	37.96
LYRA	4.51	(1.97)	0.00	(0.93)	0.00	0.00	7.44	(9.00)	66.89
APVO	4.45	(1.66)	0.00	(0.98)	0.00	0.00	7.81	(9.42)	45.42
GLTO	11.34	2.43	0.36	0.41	7.50	(15.18)	17.97	(14.66)	273.14
PHIO	3.08	(1.21)	0.00	(0.38)	0.00	0.00	4.88	(9.27)	19.15
HCWB	4.59	(1.95)	0.00	(0.68)	0.00	0.00	8.72	(11.97)	41.72
KPRX	2.74	(0.38)	0.00	(0.17)	0.00	0.00	5.32	(6.25)	21.80
APRE	3.20	(0.70)	0.00	(3.72)	0.00	0.00	4.44	(8.40)	17.87
BOLT	2.81	0.14	0.03	0.30	3.46	(3.04)	7.68	(6.43)	16.48
ACXP	4.68	(1.50)	0.00	(0.68)	0.00	0.00	10.84	(9.84)	49.19

Transcode Therapeutics Corporate Management

RN MBA	Senior Operations	Profile
Daniel MD	Chief Officer	Profile
Anna Moore	Scientific CoFounder	Profile
Calais Pharm	Executive Board	Profile
Robert Dudley	CEO, CoFounder	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC